Afya (NASDAQ:AFYA) Hits New 12-Month Low - Here's What Happened

Key Points

• Afya shares hit a new 52-week low, falling 5.3% to approximately $13.00 after trading as low as $12.75.
• Afya and Yduqs agreed to merge, creating an education group with about 1.6 million students and R$9.4 billion in revenue; Afya shareholders are expected to own roughly 69.3% of the combined company.
• Despite potential synergies and an average analyst price target of $17.75, investor sentiment remains cautious because of listing, approval and integration uncertainties, alongside a Zacks “Strong Sell” rating.

Shares of Afya Limited (NASDAQ:AFYA - Get Free Report) reached a new 52-week low during trading on Saturday. The company traded as low as $12.75 and last traded at $13.00, with a volume of 591542 shares traded. The stock had previously closed at $13.73.

Key Afya News

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Merger creates significant scale. Afya and Yduqs signed a binding agreement to combine their operations, creating a group with approximately 1.6 million students and R$9.4 billion in revenue. Afya shareholders are expected to own about 69.3% of the combined company. Afya Limited and Yduqs Enter Into Merger Agreement
• Positive Sentiment: Potential for stronger cash generation and synergies. Management commentary highlighted faster cash-flow generation and additional consolidation opportunities. Analysts cited potential synergies of as much as R$2.8 billion, while the transaction is also reported to include approximately R$750 million in dividends. JP Morgan merger scenarios
• Positive Sentiment: Analyst valuation remains above the market price. AFYA has a consensus price target of $17.75, implying substantial potential upside from recent trading levels. Afya consensus target price
• Neutral Sentiment: Listing and transaction structure remain important questions. Reports suggest the merger could affect AFYA’s Nasdaq listing, while the share-exchange structure, approvals and integration plans still need to be completed. These uncertainties may be limiting the immediate benefit of the announcement. Afya and Yduqs listing report
• Negative Sentiment: Short interest increased sharply. One report showed short interest rising 163.2% to 1.41 million shares as of September 15, equal to roughly 5.2 days of average volume. A separate report listed zero short interest, indicating inconsistent data; the increase should therefore be treated cautiously. Zacks Strong Sell list
• Negative Sentiment: Near-term sentiment is cautious. Zacks added AFYA to its No. 5, or “Strong Sell,” ranking, adding pressure while investors assess merger execution and the company’s future trading venue.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Wall Street Zen upgraded Afya from a "hold" rating to a "buy" rating in a research note on Saturday, September 5th. Weiss Ratings downgraded Afya from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Zacks Research lowered Afya from a "hold" rating to a "strong sell" rating in a research note on Friday, August 21st. JPMorgan Chase & Co. lowered their price target on Afya from $21.50 to $21.00 and set a "neutral" rating on the stock in a research note on Monday, June 22nd. Finally, Bradesco Corretora upgraded Afya to an "outperform" rating and set a $17.00 price target for the company in a research report on Thursday. One investment analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Afya presently has an average rating of "Hold" and an average target price of $17.75.

Afya Stock Down 5.3%

The stock has a market capitalization of $1.22 billion, a price-to-earnings ratio of 7.93, a PEG ratio of 1.54 and a beta of 0.35. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The business has a fifty day moving average of $14.00 and a 200 day moving average of $14.33.

Afya (NASDAQ:AFYA - Get Free Report) last posted its earnings results on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.03. The company had revenue of $187.80 million for the quarter, compared to the consensus estimate of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. As a group, equities analysts predict that Afya Limited will post 1.86 earnings per share for the current year.

Insider Activity at Afya

In related news, VP Lélio de Souza, Jr. sold 36,204 shares of Afya stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total value of $543,060.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.80% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of AFYA. Public Employees Retirement System of Ohio purchased a new position in Afya during the 2nd quarter valued at about $67,000. Engineers Gate Manager LP purchased a new stake in Afya during the second quarter worth about $325,000. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Afya during the fourth quarter worth about $462,000. 88.02% of the stock is currently owned by hedge funds and other institutional investors.

About Afya

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya's offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.